THE ROLE OF MIRNAS BART IN THE DIAGNOSIS AND PROGNOSIS OF GASTRIC CANCER ASSOCIATED WITH THE EPSTEIN-BARR VIRUS

Authors

  • Rithele Medeiros Almeida Universidade da Amazônia- UNAMA
  • Thalia Gonçalves Goulart Universidade da Amazônia
  • Fernando Augusto Rodrigues Mello Junior

DOI:

https://doi.org/10.36557/2674-8169.2025v7n11p1299-1324

Keywords:

gastric cancer, Infection

Abstract

Introduction: Epstein-Barr virus-associated gastric cancer (GCaEBV) accounts for approximately 10% of gastric carcinomas worldwide and has distinct molecular characteristics. Among these differences, the expression of viral microRNAs in gastric tissues stands out, especially BamHI-A rightward transcripts (miR-BARTs), which modulate gene regulation pathways in EBV-associated host cells. Given the complexity of miR-BART expression in the tumor context, it is necessary to understand its activity in the tumor microenvironment to assess its influence on neoplastic gastric cells. Objectives: The objective of this study is to analyze the relevance of miR-BARTs in the diagnosis and prognosis of gastric cancer associated with the Epstein-Barr virus (EBV). Through the literature, highlight the expression of miR BART types in EBV infection in gastric carcinoma cells, discuss whether they have activity in the diagnosis and prognosis of gastric cancer, and whether they present a potential therapeutic target. Methodology: The method used was an integrative literature review through scientific article research. Data analysis was performed using the BARDIN method and organized using the URSI method. Results: Of the 3,662 articles in the literature, 15 were selected using previously established inclusion and exclusion criteria. Conclusion: Therefore, it is concluded that the expression of miR-BARTs can affect oncogenic pathways involved in EBV+ gastric carcinogenesis and that the use of inhibitors of these miR-BARTs indicates potential for diagnostic/prognostic use and for the development of targeted therapies.

Downloads

Download data is not yet available.

References

Brasil-Costa, I. et al. Detection of Epstein-Barr virus in gastric adenocarcinoma: qPCR and FISH comparison. Medical Microbiology and Immunology, v. 211, n. 1, p. 29–36, 2022. Disponível em: https://doi.org/10.1007/s00430-021-00724-3

Carvalho, R. et al. Epstein-Barr virus in gastric cancer and association with 30 bp del-latent membrane protein 1 polymorphism. Revista da Associação Médica Brasileira, v. 69, n. 5, p. e20221571–e20221571, 1 jan. 2023. Disponível em: https://doi.org/10.1590/1806-9282.20221571

Chakravorty, S.; Afzali, B.; Kazemian, M. Doenças associadas ao EBV:

terapêuticas atuais e tecnologias emergentes. Frontiers, 2024. Disponível em:

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1059133/full

De Re, V. et al. MicroRNAs BART do vírus Epstein-Barr no linfoma de Hodgkin

associado ao EBV e câncer gástrico. Agentes Infecciosos e Câncer, 2020.

Disponível em: https://infectagentscancer.biomedcentral.com/articles/10.1186/s13027-020-00307-

#citeas.

Du, C. et al. EBV-miR-BART5-5p regulates RORA to promote proliferation and migration of gastric cancer cells. PLoS ONE, v. 20, n. 7, p. e0327323–e0327323, 10 jul. 2025.Disponível em: https://doi.org/10.1371/journal.pone.0327323

Estaji, F. et al. Epstein–Barr Virus and gastric carcinoma pathogenesis with emphasis on underlying epigenetic mechanisms. Discover Oncology, v. 15, n. 1, p. 719–719, 27 nov. 2024. Disponível em: https://doi.org/10.1007/s12672-024-01619-4

Kang B, W et al. High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer. Oncotarget v. 8, n. 9, p. 14988–14994, 19 jan. 2017. Disponível em: https://doi.org/10.18632/oncotarget.14744

Li, J. et al. EBV-miR-BART12 inhibits cell migration and proliferation by targeting Snail expression in EBV-associated gastric cancer. Archives of Virology, v. 166, n. 5, p. 1313–1323, 1 mar. 2021. Disponível em: https://doi.org/10.1007/s00705-021-05001-5

Onoyama, T.; Ishikawa , S. ; Isomoto , H.. Câncer gástrico e genômica:

revisão da literatura. Jornal de Gastroenterologia, 2022. Disponível em:

https://link.springer.com/article/10.1007/s00535-022-01879-3.

Park, M. C. et al. Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3. International Journal of Molecular Sciences, v. 22, n. 20, p. 10936, 10 out. 2021. Disponível em: https://doi.org/10.3390/ijms222010936

PRODANOV, Cleber Cristiano; DE FREITAS, Ernani Cesar. Metodologia do trabalho científico: métodos e técnicas da pesquisa e do trabalho acadêmico-2ª Edição. Editora Feevale, 2013.

SALNIKOV, M. Y.; MACNEIL, K. M.; MYMRYK, J. S. The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape. Frontiers in Immunology, v. 15, 26 mar. 2024. Disponível em: https://doi.org/10.3389/fimmu.2024.1358511

Severino. A. J. Metodologia do trabalho científico. [s.l.] São Paulo – Sp. Editora Cortez, 2014.

Song, Y. et al. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer. Virology, v. 548, p. 6–16, 2 jun. 2020. Disponível em: https://doi.org/10.1016/j.virol.2020.05.011

Torres, K. et al. EBV miR-BARTs and human lncRNAs: Shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, v. 1867, n. 4, p. 166049, abr. 2021. Disponível em: https://doi.org/10.1016/j.bbadis.2020.166049

Vidal-Realpe, A. et al. Características clínico-patológicas del adenocarcinoma gástrico asociado al virus de Epstein-Barr en una región de alta incidencia de cáncer gástrico en Colombia. Revista de Gastroenterología de México, maio 2022. Disponível em: https://doi.org/10.1016/j.rgmx.2021.10.008

Wang, H. et al. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma. Virus Genes, v. 57, n. 4, p. 358–368, 19 jun. 2021. Disponível em: https://doi.org/10.1007/s11262-021-01854-9

Wang, J. et al. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nature Communications, v. 13, n. 1, 14 fev. 2022. Disponível em: https://doi.org/10.1038/s41467-022-28479-2

Wang, J. et al. Epstein–Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer. Journal Biological Chemistry. v. 294, n. 13, p. 4854–4866, 29 mar. 2019. Disponível em: https://doi.org/10.1074/jbc.RA118.006853

Xu, M. et al. Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis. Journal of Virology, v. 97, n. 9, 8 set. 2023. Disponível em: https://doi.org/10.1128/jvi.00881-23

YANG, J. et al. Epstein–Barr virus-associated gastric cancer: A distinct subtype. Cancer Letters, v. 495, p. 191–199, dez. 2020. Disponível em: https://doi.org/10.1016/j.canlet.2020.09.019

Yang, J. et al. Epstein-Barr virus-coded miR-BART19-3p promotes proliferation of EBV-associated gastric cancer by inhibiting GADD45B. Journal of Translational Medicine, v. 23, n. 1, 25 ago. 2025. Disponível em: https://doi.org/10.1186/s12967-025-06955-9

Yang, Y.-C. et al. Dissecting the regulation of EBV’s BART miRNAs in carcinomas. Virology (New York, N.Y. Print), v. 505, p. 148–154, 1 maio 2017. Disponível em: https://doi.org/10.1016/j.virol.2017.02.013

Yoon, J. H.; MIN, K.; LEE, S. K. Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer. Microorganisms, v. 8, n. 2, p. 258–258, 15 fev. 2020. Disponível em: https://doi.org/10.3390/microorganisms8020258

Zhao, M.-H. et al. Epstein–Barr virus miR-BART4-3p regulates cell proliferation, apoptosis, and migration by targeting AXL in gastric carcinoma. Virus Genes, v. 58, n. 1, p. 23–34, 27 jan. 2022. Disponível em: https://doi.org/10.1007/s11262-021-01882-5

Zheng, X. et al. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression. Journal of Virology, v. 92, n. 23, 1 dez. 2018. Disponível em: https://doi.org/10.1128/jvi.01022-18

Published

2025-11-18

How to Cite

Almeida, R. M., Goulart , T. G., & Mello Junior , F. A. R. (2025). THE ROLE OF MIRNAS BART IN THE DIAGNOSIS AND PROGNOSIS OF GASTRIC CANCER ASSOCIATED WITH THE EPSTEIN-BARR VIRUS. Brazilian Journal of Implantology and Health Sciences, 7(11), 1299–1324. https://doi.org/10.36557/2674-8169.2025v7n11p1299-1324